News Search

In vitro neutralisation assays show REGEN-COV and AZD7442 are effective against the new SARS-CoV-2 variants

The tests conducted on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron's cocktail therapy can neutralize both.

SARS-CoV-2 B.1.351, the variant that emerged in South Africa is markedly more resistant to antibodies.

While social determinants, stigma about the virus, and continuum of care issues remain challenges to many people with HIV, The IDSA is looking to address these issues with its new guidance.